89 related articles for article (PubMed ID: 26458044)
1. Fractionated COâ‚‚Laser-Assisted Delivery of Topical 5-Fluorouracil as a Useful Modality for Treating Field Cutaneous Squamous Cell Carcinomas.
Glenn CJ; Parlette EC; Mitchell C
Dermatol Surg; 2015 Nov; 41(11):1339-42. PubMed ID: 26458044
[No Abstract] [Full Text] [Related]
2. Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil.
Nguyen BT; Gan SD; Konnikov N; Liang CA
J Am Acad Dermatol; 2015 Mar; 72(3):558-60. PubMed ID: 25687314
[No Abstract] [Full Text] [Related]
3. Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study.
Hsu SH; Gan SD; Nguyen BT; Konnikov N; Liang CA
Dermatol Surg; 2016 Sep; 42(9):1050-3. PubMed ID: 27359199
[TBL] [Abstract][Full Text] [Related]
4. Clinical resolution of vemurafenib-induced squamous cell carcinoma with topical 5-fluorouracil.
Sinha R; Larkin J; Fearfield L
Br J Dermatol; 2015 Apr; 172(4):1135-6. PubMed ID: 25234953
[No Abstract] [Full Text] [Related]
5. Case-based considerations in the treatment of actinic keratoses: utilizing combination or sequential therapy with 5-fluorouracil cream and destructive treatments.
Han A; Penrose C; Goldsmith A; Marmur ES
J Drugs Dermatol; 2010 Jul; 9(7):864-9. PubMed ID: 20677546
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
[TBL] [Abstract][Full Text] [Related]
7. 5% fluorouracil chemowraps in the management of widespread lower leg solar keratoses and squamous cell carcinoma.
Tallon B; Turnbull N
Australas J Dermatol; 2013 Nov; 54(4):313-6. PubMed ID: 23651243
[TBL] [Abstract][Full Text] [Related]
8. Metallic taste as a side effect of topical fluorouracil use.
Han SY; Youker S
J Drugs Dermatol; 2011 Oct; 10(10):1201-3. PubMed ID: 21968673
[TBL] [Abstract][Full Text] [Related]
9. Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy.
Schlemmer HP; Becker M; Bachert P; Dietz A; Rudat V; Vanselow B; Wollensack P; Zuna I; Knopp MV; Weidauer H; Wannenmacher M; van Kaick G
Cancer Res; 1999 May; 59(10):2363-9. PubMed ID: 10344745
[TBL] [Abstract][Full Text] [Related]
10. A case of an adverse reaction to topical 5-fluorouracil in irradiated skin.
Lambert T; Mullinax K; Smith J
J Drugs Dermatol; 2006 Mar; 5(3):282-3. PubMed ID: 16573264
[TBL] [Abstract][Full Text] [Related]
11. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.
Morton C; Horn M; Leman J; Tack B; Bedane C; Tjioe M; Ibbotson S; Khemis A; Wolf P
Arch Dermatol; 2006 Jun; 142(6):729-35. PubMed ID: 16785375
[TBL] [Abstract][Full Text] [Related]
12. Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule.
Jorizzo JL; Carney PS; Ko WT; Robins P; Weinkle SH; Werschler WP
Cutis; 2004 Dec; 74(6 Suppl):18-23. PubMed ID: 15666898
[TBL] [Abstract][Full Text] [Related]
13. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study.
Puri R; Jain S
Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258
[TBL] [Abstract][Full Text] [Related]
14. Intralesional 5-Fluorouracil in the Treatment of Lower Leg Squamous Cell Carcinoma.
Mackey M; Shahsavari A; Mackey VT
J Drugs Dermatol; 2018 Nov; 17(11):1241-1243. PubMed ID: 30500149
[TBL] [Abstract][Full Text] [Related]
15. Treatment of superficial ulcerative squamous cell carcinoma in three horses with topical 5-fluorouracil.
Paterson S
Vet Rec; 1997 Dec; 141(24):626-8. PubMed ID: 9447676
[TBL] [Abstract][Full Text] [Related]
16. [Three cases of radiotherapy combined with S-1 and mitomycin C for anal canal squamous cell carcinomas].
Shiozawa M; Nishimura K; Nonaka T; Yoshii T; Nakayama N; Motohashi O; Takagi S; Nakayama Y; Akaike M
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2941-3. PubMed ID: 21160276
[TBL] [Abstract][Full Text] [Related]
17. Optimizing treatments of locally advanced squamous cell carcinoma: where to go from here?
Bernier J
Oral Oncol; 2011 Oct; 47(10):931-3. PubMed ID: 21856208
[No Abstract] [Full Text] [Related]
18. A novel 0.5% fluorouracil cream is minimally absorbed into the systemic circulation yet is as effective as 5% fluorouracil cream.
Levy S; Furst K; Chern W
Cutis; 2002 Aug; 70(2 Suppl):14-21. PubMed ID: 12353676
[TBL] [Abstract][Full Text] [Related]
19. [Influence of the stratum corneum and dermis of the skin on the percutaneous absorption of fluorouracil delivered through skin patch].
Li GF; Chen JH; Kamiyama F; Yamamoto A; Chen ZL
Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):800-2. PubMed ID: 12297435
[TBL] [Abstract][Full Text] [Related]
20. The transport effect of submicron emulsions on 5-flurouracil topical application.
Huang YB; Huang CT; Tsou HY; Fu LT; Fu YS; Tsai YH; Wu PC
J Microencapsul; 2013; 30(5):425-31. PubMed ID: 23510368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
